Increasing Complexity of Drug Molecules
The development of complex drug molecules, including antibody-drug conjugates and multi-target therapies, is driving innovation in the Bioanalytical Testing Services Market. Such drugs require sophisticated analytical methodologies and highly sensitive detection techniques to ensure accurate characterization.
As drug complexity increases, testing services must adapt by offering specialized assay formats, multiplex testing, and advanced bioinformatics solutions. This evolution is positioning bioanalytical labs as indispensable partners in modern drug development.
3 Views
